Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (581-590 of 853) with videos related to

Pageof 86
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 24, 2007
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancerS Bishara, M Griffin, A Cargill, et al.
Molecular Cancer Therapeutics|May 30, 2006
Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKTNivedita Sain, Bhavani Krishnan, Michael G Ormerod, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 1998
The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interactionL S Murray, D I Jodrell, J G Morrison, et al.
International Journal of Cancer|February 20, 1995
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situD S Murphy, P McHardy, J Coutts, et al.
Journal of Medical Microbiology|May 13, 2005
Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitisCraig Winstanley, Stephen B Kaye, Timothy J Neal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatinJ B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
Ophthalmology|January 1, 2008
Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplastyPhilip D Jaycock, Mark N A Jones, John Males, et al.
European Journal of Gynaecological Oncology|May 23, 2012
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trialsJ Vitfell-Pedersen, T A Yap, V Moreno, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summaryS Rauz, S-Y Koay, B Foot, et al.
Pageof 86

Showing results (581-590 of 853) with videos related to

Sort By:
Pageof 86
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 24, 2007
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancerS Bishara, M Griffin, A Cargill, et al.
Molecular Cancer Therapeutics|May 30, 2006
Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKTNivedita Sain, Bhavani Krishnan, Michael G Ormerod, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 1998
The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interactionL S Murray, D I Jodrell, J G Morrison, et al.
International Journal of Cancer|February 20, 1995
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situD S Murphy, P McHardy, J Coutts, et al.
Journal of Medical Microbiology|May 13, 2005
Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitisCraig Winstanley, Stephen B Kaye, Timothy J Neal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatinJ B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
Ophthalmology|January 1, 2008
Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplastyPhilip D Jaycock, Mark N A Jones, John Males, et al.
European Journal of Gynaecological Oncology|May 23, 2012
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trialsJ Vitfell-Pedersen, T A Yap, V Moreno, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summaryS Rauz, S-Y Koay, B Foot, et al.
Pageof 86